New Gel Makes Alcohol 50% Less Toxic, Curbs Organ Damage
It sounds like a gimmick. Drink a couple glasses of wine and feel only half as intoxicated as you normally would — and sustain less damage to your liver and other organs.
- July 1,2024 | ISSN 1940-6967
- The National Association Of Medical Doctors
Featured Sponsors
Featured Articles
A Rare, Deadly Bacterial Infection Is On The Rise In Japan. What Is STSS?
Streptococcal toxic shock syndrome kills up to 30 percent of patients and is “highly associated” with flesh-eating infections. Symptoms include fever and a red rash.
Here Are The Top Supreme Court Health Cases To Watch
By early July, the Supreme Court will release its most controversial rulings for the 2023-2024 term. The Court's 6-3 conservative supermajority has already overturned Roe v. Wade, sharply limited affirmative action, expanded gun rights, and hampered the government's ability to address threats like COVID-19, climate change, and LGBTQ+ discrimination.
Suicide In Surgeons: The Heavy Toll Of A High-Stakes Career
For those outside the medical profession, it took a global pandemic to finally understand how pervasive distress and suicide are among medical professionals, particularly surgeons.
Why Most Medical Malpractice Claims Never See A Courtroom
In my research on the case selection criteria used by plaintiff medical malpractice attorneys, one very prominent plaintiff attorney in Maryland spills the beans. He proudly proclaims, “We, who are plaintiff attorneys, take on medical malpractice caused by doctors, but we only accept 1 out of every 37.5 cases we review.”
We All Pay A Price For Doctors' Moral Injury
Not long ago, the highly personal relationship between doctors and patients, based in selflessness and trust, respectively, was the cornerstone of healthcare. Today, though, corporatization and greed have driven a money-shaped wedge between us.
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Cancer vaccines are finally showing promise as Moderna and Merck touted promising data on an experimental skin cancer vaccine and the U.K. announced plans for a “landmark” scheme to test the technology across the country this week, after decades of research that could bring a new era of personalized medicine.
Top Physician Opportunities
Journal of Medicine Sign Up
Get the Journal of Medicine delivered to your inbox.
Thank you for subscribing.
In This Issue
- New Gel Makes Alcohol 50% Less Toxic, Curbs Organ Damage
- A Rare, Deadly Bacterial Infection Is On The Rise In Japan. What Is STSS?
- Here Are The Top Supreme Court Health Cases To Watch
- Suicide In Surgeons: The Heavy Toll Of A High-Stakes Career
- Why Most Medical Malpractice Claims Never See A Courtroom
- We All Pay A Price For Doctors' Moral Injury
- What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Archives
Masthead
-
- Editor-in Chief:
- Theodore Massey
- Editor:
- Robert Sokonow
- Editorial Staff:
- Musaba Dekau
Lin Takahashi
Thomas Levine
Cynthia Casteneda Avina
Ronald Harvinger
Lisa Andonis
